Clovis Oncology to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
September 08 2020 - 4:19PM
Business Wire
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that its
President and Chief Executive Officer, Patrick J. Mahaffy, will
present at the H.C. Wainwright 22nd Annual Global Investment
Conference on Wednesday, September 16, 2020 at 2:00 p.m. Eastern
time.
This conference is virtual and a live webcast of the
presentation can be accessed through the investor relations section
of the Company’s website at www.clovisoncology.com. Following the
live presentation, a replay of the webcast will be available on the
Company’s website for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer
agents in the U.S., Europe and additional international markets.
Clovis Oncology targets development programs at specific subsets of
cancer populations, and simultaneously develops, with partners,
diagnostic tools intended to direct a compound in development to
the population that is most likely to benefit from its use. Clovis
Oncology is headquartered in Boulder, Colorado; please visit
www.clovisoncology.com for more information, including additional
office locations in the U.S. and Europe.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200908005980/en/
Anna Sussman 303.625.5022 asussman@clovisoncology.com
Breanna Burkart 303.625.5023 bburkart@clovisoncology.com
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Sep 2023 to Sep 2024